According to Ars Technica, FDA advisors unanimously approved Moderna's mRNA vaccine, clearing a regulatory review that stalled in February when a Trump administration official refused to examine it.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton